Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BG00010 single- and multiple-ascending dose study in healthy volunteers and painful lumbar radiculopathy
NL-OMON40320Phase 1Active, not recruiting
- Sponsor
- Biogen
- Start
- Apr 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1 trial of artemin in lumbosacral radiculopathy (4 arms), sponsored by Biogen. Primary endpoints: Safety and tolerability and Pharmacokinetic serum concentrations. Started Apr 2013; status: active, not recruiting.
02
Drugs
artemin
03
Conditions
lumbosacral radiculopathy
Beyond the preview
Go deeper on NL-OMON40320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40320.